Chirag Jhaveri

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

John A. Wells, Adam R. Glassman, Allison R. Ayala et al. · Ophthalmology · 2016 · 1K citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +12

Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity

Carl W. Baker, Adam R. Glassman, Wesley T. Beaulieu et al. · JAMA · 2019 · 295 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +15

Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema

Jayashree Sahni, Sunil Patel, Pravin U. Dugel et al. · Ophthalmology · 2019 · 272 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Faricimab Treat-and-Extend for Diabetic Macular Edema

Tien Yin Wong, Zdenka Hašková, Kemal Asik et al. · Ophthalmology · 2023 · 138 citations · Full text

Medicine, Ophthalmology, Surgery +9

Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy

Andrew N. Antoszyk, Adam R. Glassman, Wesley T. Beaulieu et al. · JAMA · 2020 · 136 citations · Full text

Medicine, Ophthalmology, Surgery +17